<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://homologacao.aibrazil.tec.br/wp-sitemap.xsl" ?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"><url><loc>https://homologacao.aibrazil.tec.br/publicacao-cientifica/nota-tecnica-analise-de-efetividade-da-vacinacao-da-covid-19-no-brasil-para-casos-de-hospitalizacao-ou-obito/</loc><lastmod>2026-07-24T10:56:40-03:00</lastmod></url><url><loc>https://homologacao.aibrazil.tec.br/publicacao-cientifica/the-effectiveness-of-covid-19-vaccines-against-severe-cases-and-deaths-in-brazil-from-2021-to-2022-a-registry-based-study/</loc><lastmod>2026-07-24T10:59:47-03:00</lastmod></url><url><loc>https://homologacao.aibrazil.tec.br/publicacao-cientifica/the-impact-of-vaccination-on-the-length-of-stay-of-hospitalized-covid-19-patients-in-brazil/</loc><lastmod>2026-07-24T11:01:51-03:00</lastmod></url><url><loc>https://homologacao.aibrazil.tec.br/publicacao-cientifica/estimated-covid-19-severe-cases-and-deaths-averted-in-the-first-year-of-the-vaccination-campaign-in-brazil/</loc><lastmod>2026-07-24T11:03:03-03:00</lastmod></url><url><loc>https://homologacao.aibrazil.tec.br/publicacao-cientifica/immunogenicity-and-safety-to-sars-cov-2-vaccination-in-patients-with-systemic-vasculitis/</loc><lastmod>2026-07-24T16:14:17-03:00</lastmod></url><url><loc>https://homologacao.aibrazil.tec.br/publicacao-cientifica/predictors-of-hospitalization-in-breakthrough-covid-19-among-fully-vaccinated-individuals-with-immune-mediated-rheumatic-diseases-data-from-safer-study/</loc><lastmod>2026-07-24T15:48:45-03:00</lastmod></url><url><loc>https://homologacao.aibrazil.tec.br/publicacao-cientifica/safety-of-coronavac-and-chadox1-vaccines-against-sars-cov-2-in-patients-with-rheumatoid-arthritis-data-from-the-brazilian-multicentric-study-safer/</loc><lastmod>2026-07-24T15:54:03-03:00</lastmod></url><url><loc>https://homologacao.aibrazil.tec.br/publicacao-cientifica/primary-and-booster-covid-19-vaccination-in-patients-with-sjogrens-disease-data-from-the-longitudinal-safer-cohort-study/</loc><lastmod>2026-07-24T15:57:44-03:00</lastmod></url><url><loc>https://homologacao.aibrazil.tec.br/publicacao-cientifica/immunogenicity-and-safety-according-to-immunosuppressive-drugs-and-different-covid-19-vaccine-platforms-in-immune-mediated-disease-data-from-safer-cohort/</loc><lastmod>2026-07-24T16:04:25-03:00</lastmod></url><url><loc>https://homologacao.aibrazil.tec.br/publicacao-cientifica/comparison-of-the-immunogenicity-and-safety-among-covid-19-vaccines-chadox-1-coronavac-and-bnt162b2-in-systemic-lupus-erythematosus-sle-patients-a-prospective-cohort/</loc><lastmod>2026-07-24T16:06:06-03:00</lastmod></url><url><loc>https://homologacao.aibrazil.tec.br/publicacao-cientifica/immunogenicity-of-sars-cov-2-vaccination-schedules-including-a-booster-dose-in-patients-with-systemic-lupus-erythematosus-data-from-a-prospective-multicenter-study/</loc><lastmod>2026-07-24T16:07:28-03:00</lastmod></url><url><loc>https://homologacao.aibrazil.tec.br/publicacao-cientifica/impact-of-sars-cov-2-vaccination-on-disease-activity-and-severity-of-covid-19-infection-in-patients-with-systemic-lupus-erythematosus-a-multicenter-cohort-study/</loc><lastmod>2026-07-24T16:08:15-03:00</lastmod></url></urlset>
